These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 27783665

  • 21. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
    Zanichelli A, Wu MA, Andreoli A, Mansi M, Cicardi M.
    Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
    [Abstract] [Full Text] [Related]

  • 22. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
    Bork K.
    Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
    [Abstract] [Full Text] [Related]

  • 23. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.
    Jacobs J, Neeno T.
    Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830
    [Abstract] [Full Text] [Related]

  • 24. Diagnosis and treatment of hereditary angioedema.
    Canonica GW, Rossi O.
    Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
    [Abstract] [Full Text] [Related]

  • 25. Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs.
    Hurler L, Toonen EJM, Kajdácsi E, van Bree B, Brandwijk RJMGE, de Bruin W, Lyons PA, Bergamaschi L, Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration, Sinkovits G, Cervenak L, Würzner R, Prohászka Z.
    Front Immunol; 2022 Sep; 13():1039765. PubMed ID: 36420270
    [Abstract] [Full Text] [Related]

  • 26. Emotional processes and stress in children affected by hereditary angioedema with C1-inhibitor deficiency: a multicenter, prospective study.
    Savarese L, Bova M, De Falco R, Guarino MD, De Luca Picione R, Petraroli A, Senter R, Traverso C, Zabotto M, Zanichelli A, Zito E, Alessio M, Cancian M, Cicardi M, Franzese A, Perricone R, Marone G, Valerio P, Freda MF.
    Orphanet J Rare Dis; 2018 Jul 13; 13(1):115. PubMed ID: 30005674
    [Abstract] [Full Text] [Related]

  • 27. Hereditary angioedema due to C1-inhibitor deficiency in Macedonia: clinical characteristics, novel SERPING1 mutations and genetic factors modifying the clinical phenotype.
    Grivčeva-Panovska V, Košnik M, Korošec P, Andrejević S, Karadža-Lapić L, Rijavec M.
    Ann Med; 2018 May 13; 50(3):269-276. PubMed ID: 29513108
    [Abstract] [Full Text] [Related]

  • 28. A monoclonal antibody raised against human beta-factor XIIa which also recognizes alpha-factor XIIa but not factor XII or complexes of factor XIIa with C1 esterase inhibitor.
    Esnouf MP, Burgess AI, Dodds AW, Sarphie AF, Miller GJ.
    Thromb Haemost; 2000 Jun 13; 83(6):874-81. PubMed ID: 10896241
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema.
    Davis AE.
    Ann Allergy Asthma Immunol; 2008 Jan 13; 100(1 Suppl 2):S7-12. PubMed ID: 18220146
    [Abstract] [Full Text] [Related]

  • 31. Hereditary angioedema: Pathophysiology (HAE type I, HAE type II, and HAE nC1-INH).
    Wedner HJ.
    Allergy Asthma Proc; 2020 Nov 01; 41(Suppl 1):S14-S17. PubMed ID: 33109319
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Hereditary and acquired angioedema.
    Patel G, Pongracic JA.
    Allergy Asthma Proc; 2019 Nov 01; 40(6):441-445. PubMed ID: 31690390
    [Abstract] [Full Text] [Related]

  • 34. A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum.
    Kőhalmi KV, Veszeli N, Cervenak L, Varga L, Farkas H.
    Immunol Lett; 2017 Sep 01; 189():90-93. PubMed ID: 28577900
    [Abstract] [Full Text] [Related]

  • 35. The role of ficolins and MASPs in hereditary angioedema due to C1-inhibitor deficiency.
    Csuka D, Munthe-Fog L, Skjoedt MO, Kocsis A, Zotter Z, Gál P, Varga L, Farkas H, Füst G, Garred P.
    Mol Immunol; 2013 Jul 01; 54(3-4):271-7. PubMed ID: 23318225
    [Abstract] [Full Text] [Related]

  • 36. Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1.
    Kajdácsi E, Jani PK, Csuka D, Varga L, Prohászka Z, Farkas H, Cervenak L.
    J Clin Immunol; 2016 Feb 01; 36(2):160-70. PubMed ID: 26873707
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.
    Castelli R, Zanichelli A, Cugno M.
    Immunopharmacol Immunotoxicol; 2013 Feb 01; 35(1):181-90. PubMed ID: 23137231
    [Abstract] [Full Text] [Related]

  • 40. Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children.
    Reshef A, Grivcheva-Panovska V, Kessel A, Kivity S, Klimaszewska-Rembiasz M, Moldovan D, Farkas H, Gutova V, Fritz S, Relan A, Giannetti B, Magerl M.
    Pediatr Allergy Immunol; 2019 Aug 01; 30(5):562-568. PubMed ID: 30993784
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.